BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20304949)

  • 1. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
    Gazzerro E; Assereto S; Bonetto A; Sotgia F; Scarfì S; Pistorio A; Bonuccelli G; Cilli M; Bruno C; Zara F; Lisanti MP; Minetti C
    Am J Pathol; 2010 Apr; 176(4):1863-77. PubMed ID: 20304949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
    Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
    Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment.
    Assereto S; Stringara S; Sotgia F; Bonuccelli G; Broccolini A; Pedemonte M; Traverso M; Biancheri R; Zara F; Bruno C; Lisanti MP; Minetti C
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C577-82. PubMed ID: 16192300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.
    Bonuccelli G; Sotgia F; Schubert W; Park DS; Frank PG; Woodman SE; Insabato L; Cammer M; Minetti C; Lisanti MP
    Am J Pathol; 2003 Oct; 163(4):1663-75. PubMed ID: 14507673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
    Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
    PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
    Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy.
    Assereto S; Piccirillo R; Baratto S; Scudieri P; Fiorillo C; Massacesi M; Traverso M; Galietta LJ; Bruno C; Minetti C; Zara F; Gazzerro E
    Lab Invest; 2016 Aug; 96(8):862-71. PubMed ID: 27295345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: a new model of Becker muscular dystrophy.
    Teramoto N; Sugihara H; Yamanouchi K; Nakamura K; Kimura K; Okano T; Shiga T; Shirakawa T; Matsuo M; Nagata T; Daimon M; Matsuwaki T; Nishihara M
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32859695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.
    Miller G; Moore CJ; Terry R; La Riviere T; Mitchell A; Piggott R; Dear TN; Wells DJ; Winder SJ
    Hum Mol Genet; 2012 Oct; 21(20):4508-20. PubMed ID: 22810924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
    Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
    Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R; Yokota T
    Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
    Li D; Long C; Yue Y; Duan D
    Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.
    Bertoni C; Lau C; Rando TA
    Hum Mol Genet; 2003 May; 12(10):1087-99. PubMed ID: 12719373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
    Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-proportional proteasomal degradation of missense dystrophins.
    Talsness DM; Belanto JJ; Ervasti JM
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12414-9. PubMed ID: 26392559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.